nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—CHRM5—Nicardipine—hypertension	0.155	0.369	CbGbCtD
Methylscopolamine bromide—CHRM3—Nicardipine—hypertension	0.0991	0.236	CbGbCtD
Methylscopolamine bromide—CHRM1—Nicardipine—hypertension	0.0862	0.205	CbGbCtD
Methylscopolamine bromide—CHRM2—Nicardipine—hypertension	0.0795	0.189	CbGbCtD
Methylscopolamine bromide—Insomnia—Trandolapril—hypertension	0.000252	0.000712	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Irbesartan—hypertension	0.000251	0.00071	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Furosemide—hypertension	0.000251	0.000709	CcSEcCtD
Methylscopolamine bromide—Asthenia—Propranolol—hypertension	0.000251	0.000709	CcSEcCtD
Methylscopolamine bromide—Insomnia—Enalapril—hypertension	0.000251	0.000709	CcSEcCtD
Methylscopolamine bromide—Confusional state—Betaxolol—hypertension	0.00025	0.000708	CcSEcCtD
Methylscopolamine bromide—Tension—Ramipril—hypertension	0.00025	0.000706	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Indapamide—hypertension	0.000249	0.000705	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Diltiazem—hypertension	0.000249	0.000705	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Hydrochlorothiazide—hypertension	0.000249	0.000704	CcSEcCtD
Methylscopolamine bromide—Nausea—Eprosartan—hypertension	0.000248	0.000701	CcSEcCtD
Methylscopolamine bromide—Somnolence—Trandolapril—hypertension	0.000247	0.0007	CcSEcCtD
Methylscopolamine bromide—Insomnia—Telmisartan—hypertension	0.000247	0.000699	CcSEcCtD
Methylscopolamine bromide—Nervousness—Ramipril—hypertension	0.000247	0.000699	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Losartan—hypertension	0.000247	0.000698	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Carvedilol—hypertension	0.000247	0.000698	CcSEcCtD
Methylscopolamine bromide—Somnolence—Enalapril—hypertension	0.000246	0.000697	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Olmesartan—hypertension	0.000245	0.000694	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Doxazosin—hypertension	0.000244	0.00069	CcSEcCtD
Methylscopolamine bromide—Confusional state—Losartan—hypertension	0.000244	0.00069	CcSEcCtD
Methylscopolamine bromide—Tension—Timolol—hypertension	0.000244	0.00069	CcSEcCtD
Methylscopolamine bromide—Constipation—Clonidine—hypertension	0.000244	0.00069	CcSEcCtD
Methylscopolamine bromide—Somnolence—Telmisartan—hypertension	0.000243	0.000687	CcSEcCtD
Methylscopolamine bromide—Asthenia—Indapamide—hypertension	0.000243	0.000686	CcSEcCtD
Methylscopolamine bromide—Asthenia—Diltiazem—hypertension	0.000243	0.000686	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Betaxolol—hypertension	0.000242	0.000686	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Losartan—hypertension	0.000242	0.000685	CcSEcCtD
Methylscopolamine bromide—Vomiting—Guanabenz—hypertension	0.000242	0.000684	CcSEcCtD
Methylscopolamine bromide—Vomiting—Metoprolol—hypertension	0.000242	0.000684	CcSEcCtD
Methylscopolamine bromide—Nervousness—Timolol—hypertension	0.000242	0.000683	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Fosinopril—hypertension	0.000241	0.000682	CcSEcCtD
Methylscopolamine bromide—Nausea—Nisoldipine—hypertension	0.000241	0.00068	CcSEcCtD
Methylscopolamine bromide—Nausea—Amlodipine—hypertension	0.000241	0.00068	CcSEcCtD
Methylscopolamine bromide—Insomnia—Captopril—hypertension	0.00024	0.00068	CcSEcCtD
Methylscopolamine bromide—Asthenia—Carvedilol—hypertension	0.00024	0.00068	CcSEcCtD
Methylscopolamine bromide—Headache—Guanabenz—hypertension	0.000238	0.000674	CcSEcCtD
Methylscopolamine bromide—Headache—Metoprolol—hypertension	0.000238	0.000674	CcSEcCtD
Methylscopolamine bromide—Constipation—Trandolapril—hypertension	0.000238	0.000673	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Nifedipine—hypertension	0.000238	0.000673	CcSEcCtD
Methylscopolamine bromide—Urticaria—Valsartan—hypertension	0.000238	0.000672	CcSEcCtD
Methylscopolamine bromide—Asthenia—Doxazosin—hypertension	0.000238	0.000672	CcSEcCtD
Methylscopolamine bromide—Constipation—Enalapril—hypertension	0.000237	0.00067	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Verapamil—hypertension	0.000237	0.00067	CcSEcCtD
Methylscopolamine bromide—Urticaria—Olmesartan—hypertension	0.000237	0.000669	CcSEcCtD
Methylscopolamine bromide—Somnolence—Captopril—hypertension	0.000236	0.000668	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Losartan—hypertension	0.000236	0.000668	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Clonidine—hypertension	0.000235	0.000665	CcSEcCtD
Methylscopolamine bromide—Asthenia—Fosinopril—hypertension	0.000235	0.000664	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Timolol—hypertension	0.000234	0.000663	CcSEcCtD
Methylscopolamine bromide—Constipation—Telmisartan—hypertension	0.000234	0.000661	CcSEcCtD
Methylscopolamine bromide—Insomnia—Perindopril—hypertension	0.000233	0.00066	CcSEcCtD
Methylscopolamine bromide—Asthenia—Eplerenone—hypertension	0.000233	0.00066	CcSEcCtD
Methylscopolamine bromide—Asthenia—Nifedipine—hypertension	0.000232	0.000655	CcSEcCtD
Methylscopolamine bromide—Dizziness—Propranolol—hypertension	0.000231	0.000654	CcSEcCtD
Methylscopolamine bromide—Insomnia—Hydrochlorothiazide—hypertension	0.000231	0.000653	CcSEcCtD
Methylscopolamine bromide—Asthenia—Verapamil—hypertension	0.000231	0.000652	CcSEcCtD
Methylscopolamine bromide—Somnolence—Perindopril—hypertension	0.000229	0.000649	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Trandolapril—hypertension	0.000229	0.000648	CcSEcCtD
Methylscopolamine bromide—Somnolence—Irbesartan—hypertension	0.000229	0.000647	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Enalapril—hypertension	0.000228	0.000646	CcSEcCtD
Methylscopolamine bromide—Constipation—Captopril—hypertension	0.000227	0.000643	CcSEcCtD
Methylscopolamine bromide—Somnolence—Hydrochlorothiazide—hypertension	0.000227	0.000641	CcSEcCtD
Methylscopolamine bromide—Urticaria—Clonidine—hypertension	0.000227	0.000641	CcSEcCtD
Methylscopolamine bromide—Tension—Lisinopril—hypertension	0.000226	0.00064	CcSEcCtD
Methylscopolamine bromide—Nausea—Guanabenz—hypertension	0.000226	0.000639	CcSEcCtD
Methylscopolamine bromide—Nausea—Metoprolol—hypertension	0.000226	0.000639	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Telmisartan—hypertension	0.000225	0.000637	CcSEcCtD
Methylscopolamine bromide—Palpitations—Ramipril—hypertension	0.000225	0.000636	CcSEcCtD
Methylscopolamine bromide—Insomnia—Betaxolol—hypertension	0.000225	0.000635	CcSEcCtD
Methylscopolamine bromide—Nervousness—Lisinopril—hypertension	0.000224	0.000634	CcSEcCtD
Methylscopolamine bromide—Dizziness—Indapamide—hypertension	0.000224	0.000633	CcSEcCtD
Methylscopolamine bromide—Dizziness—Diltiazem—hypertension	0.000224	0.000633	CcSEcCtD
Methylscopolamine bromide—Somnolence—Furosemide—hypertension	0.000223	0.000631	CcSEcCtD
Methylscopolamine bromide—Vomiting—Propranolol—hypertension	0.000222	0.000628	CcSEcCtD
Methylscopolamine bromide—Dizziness—Carvedilol—hypertension	0.000222	0.000626	CcSEcCtD
Methylscopolamine bromide—Urticaria—Trandolapril—hypertension	0.000221	0.000625	CcSEcCtD
Methylscopolamine bromide—Constipation—Perindopril—hypertension	0.000221	0.000624	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Valsartan—hypertension	0.000221	0.000624	CcSEcCtD
Methylscopolamine bromide—Urticaria—Enalapril—hypertension	0.00022	0.000623	CcSEcCtD
Methylscopolamine bromide—Constipation—Irbesartan—hypertension	0.00022	0.000622	CcSEcCtD
Methylscopolamine bromide—Palpitations—Timolol—hypertension	0.00022	0.000621	CcSEcCtD
Methylscopolamine bromide—Dizziness—Doxazosin—hypertension	0.000219	0.00062	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Captopril—hypertension	0.000219	0.000619	CcSEcCtD
Methylscopolamine bromide—Insomnia—Losartan—hypertension	0.000219	0.000619	CcSEcCtD
Methylscopolamine bromide—Constipation—Hydrochlorothiazide—hypertension	0.000218	0.000617	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Lisinopril—hypertension	0.000217	0.000615	CcSEcCtD
Methylscopolamine bromide—Urticaria—Telmisartan—hypertension	0.000217	0.000614	CcSEcCtD
Methylscopolamine bromide—Dizziness—Fosinopril—hypertension	0.000216	0.000612	CcSEcCtD
Methylscopolamine bromide—Somnolence—Losartan—hypertension	0.000215	0.000609	CcSEcCtD
Methylscopolamine bromide—Dizziness—Eplerenone—hypertension	0.000215	0.000608	CcSEcCtD
Methylscopolamine bromide—Vomiting—Diltiazem—hypertension	0.000215	0.000608	CcSEcCtD
Methylscopolamine bromide—Vomiting—Indapamide—hypertension	0.000215	0.000608	CcSEcCtD
Methylscopolamine bromide—Asthenia—Valsartan—hypertension	0.000215	0.000607	CcSEcCtD
Methylscopolamine bromide—Constipation—Furosemide—hypertension	0.000215	0.000607	CcSEcCtD
Methylscopolamine bromide—Asthenia—Olmesartan—hypertension	0.000214	0.000604	CcSEcCtD
Methylscopolamine bromide—Dizziness—Nifedipine—hypertension	0.000214	0.000604	CcSEcCtD
Methylscopolamine bromide—Vomiting—Carvedilol—hypertension	0.000213	0.000602	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Perindopril—hypertension	0.000213	0.000601	CcSEcCtD
Methylscopolamine bromide—Dizziness—Verapamil—hypertension	0.000213	0.000601	CcSEcCtD
Methylscopolamine bromide—Constipation—Betaxolol—hypertension	0.000212	0.000601	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Irbesartan—hypertension	0.000212	0.000599	CcSEcCtD
Methylscopolamine bromide—Headache—Diltiazem—hypertension	0.000212	0.000599	CcSEcCtD
Methylscopolamine bromide—Headache—Indapamide—hypertension	0.000212	0.000599	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Ramipril—hypertension	0.000212	0.000599	CcSEcCtD
Methylscopolamine bromide—Vomiting—Doxazosin—hypertension	0.000211	0.000596	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Hydrochlorothiazide—hypertension	0.00021	0.000595	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Clonidine—hypertension	0.00021	0.000594	CcSEcCtD
Methylscopolamine bromide—Headache—Carvedilol—hypertension	0.00021	0.000593	CcSEcCtD
Methylscopolamine bromide—Confusional state—Ramipril—hypertension	0.000209	0.000592	CcSEcCtD
Methylscopolamine bromide—Vomiting—Fosinopril—hypertension	0.000208	0.000588	CcSEcCtD
Methylscopolamine bromide—Nausea—Propranolol—hypertension	0.000208	0.000587	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Ramipril—hypertension	0.000208	0.000587	CcSEcCtD
Methylscopolamine bromide—Headache—Doxazosin—hypertension	0.000208	0.000587	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Timolol—hypertension	0.000207	0.000585	CcSEcCtD
Methylscopolamine bromide—Constipation—Losartan—hypertension	0.000207	0.000585	CcSEcCtD
Methylscopolamine bromide—Vomiting—Eplerenone—hypertension	0.000207	0.000585	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Furosemide—hypertension	0.000207	0.000585	CcSEcCtD
Methylscopolamine bromide—Vomiting—Nifedipine—hypertension	0.000205	0.000581	CcSEcCtD
Methylscopolamine bromide—Urticaria—Perindopril—hypertension	0.000205	0.00058	CcSEcCtD
Methylscopolamine bromide—Headache—Fosinopril—hypertension	0.000205	0.00058	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Trandolapril—hypertension	0.000205	0.00058	CcSEcCtD
Methylscopolamine bromide—Asthenia—Clonidine—hypertension	0.000205	0.000579	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Betaxolol—hypertension	0.000205	0.000579	CcSEcCtD
Methylscopolamine bromide—Confusional state—Timolol—hypertension	0.000205	0.000579	CcSEcCtD
Methylscopolamine bromide—Vomiting—Verapamil—hypertension	0.000204	0.000578	CcSEcCtD
Methylscopolamine bromide—Urticaria—Irbesartan—hypertension	0.000204	0.000578	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Enalapril—hypertension	0.000204	0.000577	CcSEcCtD
Methylscopolamine bromide—Palpitations—Lisinopril—hypertension	0.000204	0.000576	CcSEcCtD
Methylscopolamine bromide—Headache—Eplerenone—hypertension	0.000204	0.000576	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Timolol—hypertension	0.000203	0.000574	CcSEcCtD
Methylscopolamine bromide—Urticaria—Hydrochlorothiazide—hypertension	0.000203	0.000573	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Ramipril—hypertension	0.000203	0.000573	CcSEcCtD
Methylscopolamine bromide—Headache—Nifedipine—hypertension	0.000202	0.000572	CcSEcCtD
Methylscopolamine bromide—Headache—Verapamil—hypertension	0.000201	0.00057	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Telmisartan—hypertension	0.000201	0.00057	CcSEcCtD
Methylscopolamine bromide—Nausea—Diltiazem—hypertension	0.000201	0.000568	CcSEcCtD
Methylscopolamine bromide—Nausea—Indapamide—hypertension	0.000201	0.000568	CcSEcCtD
Methylscopolamine bromide—Asthenia—Trandolapril—hypertension	0.0002	0.000565	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Losartan—hypertension	0.000199	0.000564	CcSEcCtD
Methylscopolamine bromide—Urticaria—Furosemide—hypertension	0.000199	0.000564	CcSEcCtD
Methylscopolamine bromide—Nausea—Carvedilol—hypertension	0.000199	0.000563	CcSEcCtD
Methylscopolamine bromide—Asthenia—Enalapril—hypertension	0.000199	0.000562	CcSEcCtD
Methylscopolamine bromide—Dizziness—Valsartan—hypertension	0.000198	0.00056	CcSEcCtD
Methylscopolamine bromide—Urticaria—Betaxolol—hypertension	0.000197	0.000558	CcSEcCtD
Methylscopolamine bromide—Dizziness—Olmesartan—hypertension	0.000197	0.000557	CcSEcCtD
Methylscopolamine bromide—Nausea—Doxazosin—hypertension	0.000197	0.000557	CcSEcCtD
Methylscopolamine bromide—Asthenia—Telmisartan—hypertension	0.000196	0.000555	CcSEcCtD
Methylscopolamine bromide—Nausea—Fosinopril—hypertension	0.000194	0.00055	CcSEcCtD
Methylscopolamine bromide—Nausea—Eplerenone—hypertension	0.000193	0.000546	CcSEcCtD
Methylscopolamine bromide—Urticaria—Losartan—hypertension	0.000192	0.000544	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Lisinopril—hypertension	0.000192	0.000543	CcSEcCtD
Methylscopolamine bromide—Nausea—Nifedipine—hypertension	0.000192	0.000542	CcSEcCtD
Methylscopolamine bromide—Nausea—Verapamil—hypertension	0.000191	0.00054	CcSEcCtD
Methylscopolamine bromide—Asthenia—Captopril—hypertension	0.000191	0.000539	CcSEcCtD
Methylscopolamine bromide—Vomiting—Valsartan—hypertension	0.00019	0.000538	CcSEcCtD
Methylscopolamine bromide—Confusional state—Lisinopril—hypertension	0.00019	0.000537	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Irbesartan—hypertension	0.00019	0.000536	CcSEcCtD
Methylscopolamine bromide—Vomiting—Olmesartan—hypertension	0.000189	0.000536	CcSEcCtD
Methylscopolamine bromide—Dizziness—Clonidine—hypertension	0.000189	0.000534	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Lisinopril—hypertension	0.000188	0.000532	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Hydrochlorothiazide—hypertension	0.000188	0.000532	CcSEcCtD
Methylscopolamine bromide—Insomnia—Ramipril—hypertension	0.000188	0.000531	CcSEcCtD
Methylscopolamine bromide—Headache—Valsartan—hypertension	0.000188	0.00053	CcSEcCtD
Methylscopolamine bromide—Headache—Olmesartan—hypertension	0.000187	0.000528	CcSEcCtD
Methylscopolamine bromide—Asthenia—Perindopril—hypertension	0.000185	0.000524	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Furosemide—hypertension	0.000185	0.000523	CcSEcCtD
Methylscopolamine bromide—Asthenia—Irbesartan—hypertension	0.000185	0.000522	CcSEcCtD
Methylscopolamine bromide—Somnolence—Ramipril—hypertension	0.000185	0.000522	CcSEcCtD
Methylscopolamine bromide—Dizziness—Trandolapril—hypertension	0.000184	0.00052	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Lisinopril—hypertension	0.000184	0.00052	CcSEcCtD
Methylscopolamine bromide—Insomnia—Timolol—hypertension	0.000184	0.000519	CcSEcCtD
Methylscopolamine bromide—Dizziness—Enalapril—hypertension	0.000183	0.000518	CcSEcCtD
Methylscopolamine bromide—Asthenia—Hydrochlorothiazide—hypertension	0.000183	0.000518	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Betaxolol—hypertension	0.000183	0.000518	CcSEcCtD
Methylscopolamine bromide—Vomiting—Clonidine—hypertension	0.000181	0.000513	CcSEcCtD
Methylscopolamine bromide—Dizziness—Telmisartan—hypertension	0.000181	0.000511	CcSEcCtD
Methylscopolamine bromide—Somnolence—Timolol—hypertension	0.00018	0.00051	CcSEcCtD
Methylscopolamine bromide—Asthenia—Furosemide—hypertension	0.00018	0.000509	CcSEcCtD
Methylscopolamine bromide—Headache—Clonidine—hypertension	0.000179	0.000505	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Losartan—hypertension	0.000178	0.000504	CcSEcCtD
Methylscopolamine bromide—Asthenia—Betaxolol—hypertension	0.000178	0.000504	CcSEcCtD
Methylscopolamine bromide—Nausea—Valsartan—hypertension	0.000178	0.000503	CcSEcCtD
Methylscopolamine bromide—Constipation—Ramipril—hypertension	0.000178	0.000502	CcSEcCtD
Methylscopolamine bromide—Nausea—Olmesartan—hypertension	0.000177	0.0005	CcSEcCtD
Methylscopolamine bromide—Vomiting—Trandolapril—hypertension	0.000177	0.0005	CcSEcCtD
Methylscopolamine bromide—Vomiting—Enalapril—hypertension	0.000176	0.000498	CcSEcCtD
Methylscopolamine bromide—Dizziness—Captopril—hypertension	0.000176	0.000497	CcSEcCtD
Methylscopolamine bromide—Headache—Trandolapril—hypertension	0.000174	0.000493	CcSEcCtD
Methylscopolamine bromide—Vomiting—Telmisartan—hypertension	0.000174	0.000492	CcSEcCtD
Methylscopolamine bromide—Asthenia—Losartan—hypertension	0.000174	0.000491	CcSEcCtD
Methylscopolamine bromide—Headache—Enalapril—hypertension	0.000174	0.000491	CcSEcCtD
Methylscopolamine bromide—Headache—Telmisartan—hypertension	0.000171	0.000484	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Ramipril—hypertension	0.000171	0.000484	CcSEcCtD
Methylscopolamine bromide—Dizziness—Perindopril—hypertension	0.000171	0.000483	CcSEcCtD
Methylscopolamine bromide—Insomnia—Lisinopril—hypertension	0.00017	0.000481	CcSEcCtD
Methylscopolamine bromide—Dizziness—Irbesartan—hypertension	0.00017	0.000481	CcSEcCtD
Methylscopolamine bromide—Nausea—Clonidine—hypertension	0.000169	0.000479	CcSEcCtD
Methylscopolamine bromide—Vomiting—Captopril—hypertension	0.000169	0.000478	CcSEcCtD
Methylscopolamine bromide—Dizziness—Hydrochlorothiazide—hypertension	0.000169	0.000477	CcSEcCtD
Methylscopolamine bromide—Somnolence—Lisinopril—hypertension	0.000167	0.000473	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Timolol—hypertension	0.000167	0.000473	CcSEcCtD
Methylscopolamine bromide—Headache—Captopril—hypertension	0.000167	0.000471	CcSEcCtD
Methylscopolamine bromide—Dizziness—Furosemide—hypertension	0.000166	0.000469	CcSEcCtD
Methylscopolamine bromide—Nausea—Trandolapril—hypertension	0.000165	0.000467	CcSEcCtD
Methylscopolamine bromide—Urticaria—Ramipril—hypertension	0.000165	0.000466	CcSEcCtD
Methylscopolamine bromide—Nausea—Enalapril—hypertension	0.000165	0.000466	CcSEcCtD
Methylscopolamine bromide—Dizziness—Betaxolol—hypertension	0.000164	0.000464	CcSEcCtD
Methylscopolamine bromide—Vomiting—Perindopril—hypertension	0.000164	0.000464	CcSEcCtD
Methylscopolamine bromide—Vomiting—Irbesartan—hypertension	0.000164	0.000462	CcSEcCtD
Methylscopolamine bromide—Nausea—Telmisartan—hypertension	0.000162	0.000459	CcSEcCtD
Methylscopolamine bromide—Vomiting—Hydrochlorothiazide—hypertension	0.000162	0.000459	CcSEcCtD
Methylscopolamine bromide—Headache—Perindopril—hypertension	0.000162	0.000457	CcSEcCtD
Methylscopolamine bromide—Urticaria—Timolol—hypertension	0.000161	0.000456	CcSEcCtD
Methylscopolamine bromide—Headache—Irbesartan—hypertension	0.000161	0.000456	CcSEcCtD
Methylscopolamine bromide—Constipation—Lisinopril—hypertension	0.000161	0.000455	CcSEcCtD
Methylscopolamine bromide—Dizziness—Losartan—hypertension	0.00016	0.000453	CcSEcCtD
Methylscopolamine bromide—Headache—Hydrochlorothiazide—hypertension	0.00016	0.000452	CcSEcCtD
Methylscopolamine bromide—Vomiting—Furosemide—hypertension	0.00016	0.000451	CcSEcCtD
Methylscopolamine bromide—Vomiting—Betaxolol—hypertension	0.000158	0.000447	CcSEcCtD
Methylscopolamine bromide—Nausea—Captopril—hypertension	0.000158	0.000446	CcSEcCtD
Methylscopolamine bromide—Headache—Furosemide—hypertension	0.000157	0.000444	CcSEcCtD
Methylscopolamine bromide—Headache—Betaxolol—hypertension	0.000156	0.00044	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Lisinopril—hypertension	0.000155	0.000439	CcSEcCtD
Methylscopolamine bromide—Vomiting—Losartan—hypertension	0.000154	0.000435	CcSEcCtD
Methylscopolamine bromide—Nausea—Perindopril—hypertension	0.000153	0.000434	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Ramipril—hypertension	0.000153	0.000432	CcSEcCtD
Methylscopolamine bromide—Nausea—Irbesartan—hypertension	0.000153	0.000432	CcSEcCtD
Methylscopolamine bromide—Headache—Losartan—hypertension	0.000152	0.000429	CcSEcCtD
Methylscopolamine bromide—Nausea—Hydrochlorothiazide—hypertension	0.000152	0.000429	CcSEcCtD
Methylscopolamine bromide—Urticaria—Lisinopril—hypertension	0.00015	0.000423	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Timolol—hypertension	0.00015	0.000423	CcSEcCtD
Methylscopolamine bromide—Nausea—Furosemide—hypertension	0.000149	0.000421	CcSEcCtD
Methylscopolamine bromide—Asthenia—Ramipril—hypertension	0.000149	0.000421	CcSEcCtD
Methylscopolamine bromide—Nausea—Betaxolol—hypertension	0.000148	0.000417	CcSEcCtD
Methylscopolamine bromide—Asthenia—Timolol—hypertension	0.000146	0.000412	CcSEcCtD
Methylscopolamine bromide—Nausea—Losartan—hypertension	0.000144	0.000407	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Lisinopril—hypertension	0.000139	0.000392	CcSEcCtD
Methylscopolamine bromide—Dizziness—Ramipril—hypertension	0.000137	0.000388	CcSEcCtD
Methylscopolamine bromide—Asthenia—Lisinopril—hypertension	0.000135	0.000382	CcSEcCtD
Methylscopolamine bromide—Dizziness—Timolol—hypertension	0.000134	0.000379	CcSEcCtD
Methylscopolamine bromide—Vomiting—Ramipril—hypertension	0.000132	0.000373	CcSEcCtD
Methylscopolamine bromide—Headache—Ramipril—hypertension	0.00013	0.000368	CcSEcCtD
Methylscopolamine bromide—Vomiting—Timolol—hypertension	0.000129	0.000365	CcSEcCtD
Methylscopolamine bromide—Headache—Timolol—hypertension	0.000127	0.000359	CcSEcCtD
Methylscopolamine bromide—Dizziness—Lisinopril—hypertension	0.000124	0.000352	CcSEcCtD
Methylscopolamine bromide—Nausea—Ramipril—hypertension	0.000123	0.000349	CcSEcCtD
Methylscopolamine bromide—Nausea—Timolol—hypertension	0.000121	0.000341	CcSEcCtD
Methylscopolamine bromide—Vomiting—Lisinopril—hypertension	0.00012	0.000338	CcSEcCtD
Methylscopolamine bromide—Headache—Lisinopril—hypertension	0.000118	0.000333	CcSEcCtD
Methylscopolamine bromide—Nausea—Lisinopril—hypertension	0.000112	0.000316	CcSEcCtD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—RHOA—hypertension	1.11e-05	4.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AVP—hypertension	1.1e-05	4.88e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GNAS—hypertension	1.1e-05	4.88e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GNAS—hypertension	1.1e-05	4.86e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3R1—hypertension	1.1e-05	4.85e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—RHOA—hypertension	1.1e-05	4.84e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3R1—hypertension	1.09e-05	4.84e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GNAS—hypertension	1.09e-05	4.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARA—hypertension	1.09e-05	4.8e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3R1—hypertension	1.08e-05	4.79e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOB—hypertension	1.08e-05	4.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOB—hypertension	1.08e-05	4.76e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTK2—hypertension	1.08e-05	4.76e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTK2—hypertension	1.07e-05	4.74e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCL8—hypertension	1.07e-05	4.74e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCL8—hypertension	1.07e-05	4.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOB—hypertension	1.07e-05	4.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EDN1—hypertension	1.06e-05	4.7e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTK2—hypertension	1.06e-05	4.7e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EDN1—hypertension	1.06e-05	4.69e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCL8—hypertension	1.06e-05	4.68e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—POMC—hypertension	1.06e-05	4.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL5—hypertension	1.06e-05	4.67e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AGT—hypertension	1.05e-05	4.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL5—hypertension	1.05e-05	4.65e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EDN1—hypertension	1.05e-05	4.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—INS—hypertension	1.05e-05	4.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL5—hypertension	1.04e-05	4.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CALM1—hypertension	1.04e-05	4.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL2—hypertension	1.03e-05	4.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LPL—hypertension	1.03e-05	4.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOE—hypertension	1.03e-05	4.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LPL—hypertension	1.03e-05	4.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—H2AFX—hypertension	1.03e-05	4.53e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RPS6KB1—hypertension	1.02e-05	4.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PDGFRB—hypertension	1.02e-05	4.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CAV1—hypertension	1.02e-05	4.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—H2AFX—hypertension	1.02e-05	4.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RPS6KB1—hypertension	1.02e-05	4.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PDGFRB—hypertension	1.02e-05	4.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOA1—hypertension	1.02e-05	4.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LPL—hypertension	1.02e-05	4.5e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF1—hypertension	1.02e-05	4.49e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT2—hypertension	1.02e-05	4.49e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—H2AFX—hypertension	1.01e-05	4.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADCY5—hypertension	1.01e-05	4.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—EGFR—hypertension	1.01e-05	4.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PDGFRB—hypertension	1.01e-05	4.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RPS6KB1—hypertension	1.01e-05	4.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADCY5—hypertension	1.01e-05	4.45e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCG—hypertension	1e-05	4.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCG—hypertension	1e-05	4.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADCY5—hypertension	9.98e-06	4.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ITGB3—hypertension	9.98e-06	4.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCA—hypertension	9.98e-06	4.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ITGB3—hypertension	9.94e-06	4.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCA—hypertension	9.94e-06	4.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCG—hypertension	9.91e-06	4.38e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—YWHAZ—hypertension	9.89e-06	4.37e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—YWHAZ—hypertension	9.86e-06	4.36e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCA—hypertension	9.85e-06	4.35e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ITGB3—hypertension	9.85e-06	4.35e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NGF—hypertension	9.78e-06	4.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SPP1—hypertension	9.78e-06	4.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—YWHAZ—hypertension	9.77e-06	4.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SPP1—hypertension	9.75e-06	4.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NGF—hypertension	9.75e-06	4.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCL8—hypertension	9.74e-06	4.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCL8—hypertension	9.71e-06	4.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SPP1—hypertension	9.66e-06	4.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NGF—hypertension	9.66e-06	4.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SERPINE1—hypertension	9.65e-06	4.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCL8—hypertension	9.61e-06	4.25e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCD—hypertension	9.52e-06	4.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR5—hypertension	9.52e-06	4.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR5—hypertension	9.49e-06	4.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCD—hypertension	9.49e-06	4.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR5—hypertension	9.39e-06	4.15e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCD—hypertension	9.39e-06	4.15e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FGF2—hypertension	9.34e-06	4.13e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR2A—hypertension	9.31e-06	4.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RHOA—hypertension	9.31e-06	4.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—C3—hypertension	9.3e-06	4.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR2A—hypertension	9.28e-06	4.1e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—C3—hypertension	9.27e-06	4.1e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NOS3—hypertension	9.21e-06	4.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3R1—hypertension	9.21e-06	4.07e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR2A—hypertension	9.19e-06	4.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—C3—hypertension	9.18e-06	4.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PDGFB—hypertension	9.05e-06	4e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PDGFB—hypertension	9.02e-06	3.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGFR1—hypertension	9e-06	3.98e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARG—hypertension	8.99e-06	3.97e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGFR1—hypertension	8.98e-06	3.97e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PDGFB—hypertension	8.94e-06	3.95e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGFR1—hypertension	8.89e-06	3.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HIF1A—hypertension	8.87e-06	3.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—POMC—hypertension	8.87e-06	3.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HIF1A—hypertension	8.84e-06	3.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AGT—hypertension	8.84e-06	3.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—INS—hypertension	8.82e-06	3.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AGT—hypertension	8.81e-06	3.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HIF1A—hypertension	8.75e-06	3.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AGT—hypertension	8.72e-06	3.85e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CALM1—hypertension	8.69e-06	3.84e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RELA—hypertension	8.67e-06	3.83e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CALM1—hypertension	8.66e-06	3.83e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LEP—hypertension	8.66e-06	3.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOE—hypertension	8.66e-06	3.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LEP—hypertension	8.63e-06	3.81e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOE—hypertension	8.63e-06	3.81e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CAV1—hypertension	8.58e-06	3.79e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CALM1—hypertension	8.58e-06	3.79e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOA1—hypertension	8.56e-06	3.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CAV1—hypertension	8.55e-06	3.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOE—hypertension	8.55e-06	3.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LEP—hypertension	8.55e-06	3.78e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOA1—hypertension	8.53e-06	3.77e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MTOR—hypertension	8.5e-06	3.76e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KDR—hypertension	8.48e-06	3.75e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CAV1—hypertension	8.47e-06	3.74e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KDR—hypertension	8.46e-06	3.74e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOA1—hypertension	8.45e-06	3.73e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KDR—hypertension	8.37e-06	3.7e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL8—hypertension	8.17e-06	3.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FN1—hypertension	8.16e-06	3.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—F2—hypertension	8.16e-06	3.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCB—hypertension	8.16e-06	3.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FN1—hypertension	8.14e-06	3.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCB—hypertension	8.14e-06	3.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—F2—hypertension	8.14e-06	3.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ALB—hypertension	8.08e-06	3.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FN1—hypertension	8.06e-06	3.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—F2—hypertension	8.06e-06	3.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCB—hypertension	8.06e-06	3.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOTCH1—hypertension	7.99e-06	3.53e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOTCH1—hypertension	7.96e-06	3.52e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AKT1—hypertension	7.89e-06	3.49e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOTCH1—hypertension	7.89e-06	3.48e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—hypertension	7.77e-06	3.43e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3R1—hypertension	7.73e-06	3.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—NOS3—hypertension	7.73e-06	3.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—POMC—hypertension	7.44e-06	3.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—POMC—hypertension	7.41e-06	3.28e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—INS—hypertension	7.4e-06	3.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP9—hypertension	7.39e-06	3.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—INS—hypertension	7.37e-06	3.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CDKN1A—hypertension	7.36e-06	3.25e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTEN—hypertension	7.35e-06	3.25e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—POMC—hypertension	7.34e-06	3.24e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—INS—hypertension	7.3e-06	3.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL2—hypertension	7.28e-06	3.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL2—hypertension	7.25e-06	3.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK8—hypertension	7.19e-06	3.18e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL2—hypertension	7.18e-06	3.17e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AKT1—hypertension	7.17e-06	3.17e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF1—hypertension	7.15e-06	3.16e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT2—hypertension	7.15e-06	3.16e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF1—hypertension	7.13e-06	3.15e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT2—hypertension	7.13e-06	3.15e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—EGFR—hypertension	7.12e-06	3.14e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—EGFR—hypertension	7.1e-06	3.13e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—hypertension	7.07e-06	3.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF1—hypertension	7.06e-06	3.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT2—hypertension	7.06e-06	3.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—EGFR—hypertension	7.03e-06	3.1e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EP300—hypertension	7.01e-06	3.1e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SRC—hypertension	6.81e-06	3.01e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SERPINE1—hypertension	6.79e-06	3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SERPINE1—hypertension	6.77e-06	2.99e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SERPINE1—hypertension	6.71e-06	2.96e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—VEGFA—hypertension	6.64e-06	2.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGF2—hypertension	6.58e-06	2.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGF2—hypertension	6.56e-06	2.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RHOA—hypertension	6.55e-06	2.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RHOA—hypertension	6.53e-06	2.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGF2—hypertension	6.49e-06	2.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3R1—hypertension	6.49e-06	2.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOS3—hypertension	6.49e-06	2.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RHOA—hypertension	6.47e-06	2.86e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3R1—hypertension	6.47e-06	2.86e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOS3—hypertension	6.47e-06	2.86e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3R1—hypertension	6.4e-06	2.83e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOS3—hypertension	6.4e-06	2.83e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTEN—hypertension	6.17e-06	2.72e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MYC—hypertension	6.11e-06	2.7e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RELA—hypertension	6.11e-06	2.7e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—hypertension	6.09e-06	2.69e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RELA—hypertension	6.09e-06	2.69e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RELA—hypertension	6.03e-06	2.66e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MTOR—hypertension	5.99e-06	2.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EGFR—hypertension	5.97e-06	2.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MTOR—hypertension	5.97e-06	2.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MTOR—hypertension	5.91e-06	2.61e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—EP300—hypertension	5.88e-06	2.6e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL8—hypertension	5.75e-06	2.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL8—hypertension	5.74e-06	2.53e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL8—hypertension	5.68e-06	2.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AKT1—hypertension	5.56e-06	2.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AKT1—hypertension	5.54e-06	2.45e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AKT1—hypertension	5.49e-06	2.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—hypertension	5.47e-06	2.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—hypertension	5.45e-06	2.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—hypertension	5.4e-06	2.39e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP9—hypertension	5.2e-06	2.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP9—hypertension	5.19e-06	2.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CDKN1A—hypertension	5.19e-06	2.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTEN—hypertension	5.17e-06	2.29e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CDKN1A—hypertension	5.17e-06	2.28e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTEN—hypertension	5.16e-06	2.28e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP9—hypertension	5.14e-06	2.27e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CDKN1A—hypertension	5.12e-06	2.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTEN—hypertension	5.11e-06	2.26e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK8—hypertension	5.06e-06	2.24e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AKT1—hypertension	5.05e-06	2.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK8—hypertension	5.04e-06	2.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AKT1—hypertension	5.03e-06	2.22e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TP53—hypertension	5.01e-06	2.22e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK8—hypertension	5e-06	2.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AKT1—hypertension	4.98e-06	2.2e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EP300—hypertension	4.93e-06	2.18e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EP300—hypertension	4.92e-06	2.17e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EP300—hypertension	4.87e-06	2.15e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SRC—hypertension	4.8e-06	2.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SRC—hypertension	4.78e-06	2.11e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SRC—hypertension	4.74e-06	2.09e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—VEGFA—hypertension	4.67e-06	2.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—VEGFA—hypertension	4.66e-06	2.06e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—VEGFA—hypertension	4.61e-06	2.04e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—hypertension	4.59e-06	2.03e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MYC—hypertension	4.3e-06	1.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—hypertension	4.29e-06	1.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MYC—hypertension	4.29e-06	1.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—hypertension	4.28e-06	1.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MYC—hypertension	4.24e-06	1.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT1—hypertension	4.23e-06	1.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—hypertension	4.23e-06	1.87e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EGFR—hypertension	4.21e-06	1.86e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EGFR—hypertension	4.19e-06	1.85e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EGFR—hypertension	4.15e-06	1.83e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AKT1—hypertension	3.55e-06	1.57e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TP53—hypertension	3.53e-06	1.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TP53—hypertension	3.52e-06	1.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TP53—hypertension	3.49e-06	1.54e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—hypertension	3.23e-06	1.43e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—hypertension	3.22e-06	1.42e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—hypertension	3.19e-06	1.41e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT1—hypertension	2.98e-06	1.32e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT1—hypertension	2.97e-06	1.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT1—hypertension	2.94e-06	1.3e-05	CbGpPWpGaD
